{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:31:09Z","timestamp":1791045069334,"version":"4.1.0"},"reference-count":186,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Path"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1136\/mp.52.6.307","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T19:10:34Z","timestamp":1230750634000},"page":"307-322","source":"Crossref","is-referenced-by-count":130,"title":["The Epstein-Barr virus and its association with human cancers."],"prefix":"10.1136","volume":"52","author":[{"given":"K R","family":"Baumforth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L S","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K J","family":"Flavell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Constandinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P G","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1999,12,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/JVI.30.3.852-862.1979","article-title":"DNA of Epstein-Barr virus: V. Direct repeats of the ends of Epstein-Barr virus DNA","volume":"30","author":"Given, D.; Yee, D.; Griem, K.","year":"1979","unstructured":"Given D, Yee D, Griem K, et al. DNA of Epstein-Barr virus: V. Direct repeats of the ends of Epstein-Barr virus DNA. J Virol 1979;30:852\u201362.","journal-title":"J Virol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/JVI.44.1.286-294.1982","article-title":"Long internal direct repeat in Epstein-Barr virus DNAs","volume":"44","author":"Cheung, A.; KieV, E.","year":"1982","unstructured":"Cheung A, KieV E. Long internal direct repeat in Epstein-Barr virus DNAs. J Virol 1982;44:286\u201394.","journal-title":"J Virol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJM198405103101905","article-title":"Epstein-Barr virus replication in oropharyngeal epithelial cells","volume":"310","author":"Sixbey, J.W.; Nedrud, J.G.; Raab-Traub, N.","year":"1984","unstructured":"Sixbey JW, Nedrud JG, Raab-Traub N, et al. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 1984;310:1225\u201330.","journal-title":"N Engl J Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0140-6736(72)92402-6","article-title":"Oral excretion of Epstein-Barr viruses by healthy subjects and patients with infectious mononucleosis","volume":"2","author":"Gerber, P.; Goldstein, L.; Lucas, S.","year":"1972","unstructured":"Gerber P, Goldstein L, Lucas S, et al. Oral excretion of Epstein-Barr viruses by healthy subjects and patients with infectious mononucleosis. Lancet 1972;2:988\u20139.","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1073\/pnas.59.1.94","article-title":"Relation of Burkitt\u2019s tumor-associated herpes-type virus to infectious mononucleosis","volume":"59","author":"Henle, G.; Henle, W.; Diehl, V.","year":"1968","unstructured":"Henle G, Henle W, Diehl V. Relation of Burkitt\u2019s tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA 1968;59:94\u2013101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref_6","first-page":"2397","article-title":"Epstein-Barr virus","author":"Rickinson, A.; KieV, E.","year":"1996","unstructured":"Rickinson A, KieV E. Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, eds. Fields virology. Philadelphia: Lippincot-Raven, 1996:2397\u2013446."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0065-2776(08)60339-9","article-title":"Epstein-Barr virus infection and immunoregulation in man","volume":"37","author":"Tosato, G.; Blaese, R.M.","year":"1985","unstructured":"Tosato G, Blaese RM. Epstein-Barr virus infection and immunoregulation in man. Adv Immunol 1985;37:99\u2013149.","journal-title":"Adv Immunol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/infdis\/163.6.1341","article-title":"Excretion of the EpsteinBarr-virus from the genital tract of men","volume":"163","author":"Israele, V.; Shirley, P.; Sixbey, J.W.","year":"1991","unstructured":"Israele V, Shirley P, Sixbey JW. Excretion of the EpsteinBarr-virus from the genital tract of men. J Infect Dis 1991; 163:1341\u20133.","journal-title":"J Infect Dis"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00000441-199110000-00005","article-title":"Epstein-Barr virus shedding in breast milk","volume":"302","author":"Junker, A.K.; Thomas, E.E.; RadcliVe, A.","year":"1991","unstructured":"Junker AK, Thomas EE, RadcliVe A, et al. Epstein-Barr virus shedding in breast milk. Am J Med Sci 1991;302:220\u2013 3.","journal-title":"Am J Med Sci"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0140-6736(86)90531-3","article-title":"A second site for Epstein-Barr virus shedding: the uterine cervix","volume":"2","author":"Sixbey, J.W.; Lemon, S.M.; Pagano, J.S.","year":"1986","unstructured":"Sixbey JW, Lemon SM, Pagano JS. A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet 1986;2:1122\u20134.","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1099\/0022-1317-67-10-2267","article-title":"Acyclovir eYciently inhibits oropharyngeal excretion of Epstein-Barr virus in patients with acute infectious mononucleosis","volume":"67","author":"Ernberg, I.; Andersson, J.","year":"1986","unstructured":"Ernberg I, Andersson J. Acyclovir eYciently inhibits oropharyngeal excretion of Epstein-Barr virus in patients with acute infectious mononucleosis. J Gen Virol 1986;67: 2267\u201372.","journal-title":"J Gen Virol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ijc.2910430115","article-title":"Epstein-Barr virus infected B cells persist in the circulation of acyclovir-treated virus carriers","volume":"43","author":"Yao, Q.; Ogan, P.; Rowe, M.","year":"1989","unstructured":"Yao Q, Ogan P, Rowe M, et al. Epstein-Barr virus infected B cells persist in the circulation of acyclovir-treated virus carriers. Int J Cancer 1989;43:67\u201371.","journal-title":"Int J Cancer"},{"key":"ref_13","first-page":"725","article-title":"Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients [published erratum appears in Transplantation 1990; 50","volume":"49","author":"Gratama, J.W.; Oosterveer, M.A.; Lepoutre, J.M.","year":"1990","unstructured":"Gratama JW, Oosterveer MA, Lepoutre JM, et al. Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients [published erratum appears in Transplantation 1990;50:910]. Transplantation 1990;49:725\u201330."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0042-6822(91)90893-G","article-title":"Early events in Epstein-Barr virus infection of human B-lymphocytes","volume":"181","author":"Alfieri, C.; Birkenbach, M.; KieV, E.","year":"1991","unstructured":"Alfieri C, Birkenbach M, KieV E. Early events in Epstein-Barr virus infection of human B-lymphocytes. Virology 1991;181:595\u2013608.","journal-title":"Virology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/335256a0","article-title":"Transfer of a functional human immune system to mice with severe combined immunodeficiency","volume":"335","author":"Mosier, D.E.; Gulizia, R.J.; Baird, S.M.","year":"1988","unstructured":"Mosier DE, Gulizia RJ, Baird SM, et al. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988;335:256\u20139.","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1073\/pnas.89.5.1890","article-title":"Interleukin 10 is a potent growth and diVerentiation factor for activated human B lymphocytes","volume":"89","author":"Rousset, F.; Garcia, E.; Defrance, T.","year":"1992","unstructured":"Rousset F, Garcia E, Defrance T, et al. Interleukin 10 is a potent growth and diVerentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992;89: 1890\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1182\/blood.V86.5.1893.bloodjournal8651893","article-title":"BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes","volume":"86","author":"Oudejans, J.J.; van den Brule, A.J.; Jiwa, N.M.","year":"1995","unstructured":"Oudejans JJ, van den Brule AJ, Jiwa NM, et al. BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes. Blood 1995;86: 1893\u2013902.","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2559.1995.tb00273.x","article-title":"Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin\u2019s disease: implications for diVerent pathogenic mechanisms","volume":"26","author":"Jiwa, N.M.; Oudejans, J.J.; Bai, M.C.","year":"1995","unstructured":"Jiwa NM, Oudejans JJ, Bai MC, et al. Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin\u2019s disease: implications for diVerent pathogenic mechanisms. Histopathology 1995;26: 547\u201353.","journal-title":"Histopathology"},{"key":"ref_19","first-page":"1987","article-title":"Human chromosome association of Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth","volume-title":"transformed in vitro. Proc Natl Acad Sci","volume":"80","author":"Henderson, A.; Ripley, S.; Heller, M.","year":"1983","unstructured":"Henderson A, Ripley S, Heller M, et al. Human chromosome association of Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth transformed in vitro. Proc Natl Acad Sci USA 1983;80:1987\u201391."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1099\/0022-1317-68-11-2853","article-title":"New type B isolates of Epstein-Barr virus from Burkitt\u2019s lymphoma and from normal individuals in endemic areas","volume":"68","author":"Young, L.S.; Yao, Q.Y.; Rooney, C.M.","year":"1987","unstructured":"Young LS, Yao QY, Rooney CM, et al. New type B isolates of Epstein-Barr virus from Burkitt\u2019s lymphoma and from normal individuals in endemic areas. J Gen Virol 1987;68: 2853\u201362.","journal-title":"J Gen Virol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(89)90829-5","article-title":"Detection of a second widespread strain of Epstein-Barr virus","volume":"2","author":"Sixbey, J.W.; Shirley, P.; Chesney, P.J.","year":"1989","unstructured":"Sixbey JW, Shirley P, Chesney PJ, et al. Detection of a second widespread strain of Epstein-Barr virus. Lancet 1989;2:761\u20135.","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/path.1711680212","article-title":"Distribution and localization of Epstein-Barr virus subtypes A and B in AIDSrelated lymphomas and lymphatic tissue of HIV-positive patients","volume":"168","author":"Borisch, B.; Finke, J.; Hennig, I.","year":"1992","unstructured":"Borisch B, Finke J, Hennig I, et al. Distribution and localization of Epstein-Barr virus subtypes A and B in AIDSrelated lymphomas and lymphatic tissue of HIV-positive patients. J Pathol 1992;168:229\u201336.","journal-title":"J Pathol"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ijc.2910590605","article-title":"Genotypic analysis of Epstein-Barr virus isolates associated with nasopharyngeal carcinoma in Chinese immigrants to the United States","volume":"59","author":"Lung, M.L.; Chang, G.C.; Miller, T.R.","year":"1994","unstructured":"Lung ML, Chang GC, Miller TR, et al. Genotypic analysis of Epstein-Barr virus isolates associated with nasopharyngeal carcinoma in Chinese immigrants to the United States. Int J Cancer 1994;59:743\u20136.","journal-title":"Int J Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ijc.2910560403","article-title":"Epstein-Barr virus genomes in NPC biopsies from North Africa","volume":"56","author":"Bouzid, M.; Djennaoui, D.; Dubreuil, J.","year":"1994","unstructured":"Bouzid M, Djennaoui D, Dubreuil J, et al. Epstein-Barr virus genomes in NPC biopsies from North Africa. Int J Cancer 1994;56:468\u201373.","journal-title":"Int J Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ijc.2910520203","article-title":"Direct detection of Epstein-Barr virus in peripheral blood and comparison of EBV genotype present in direct specimens and lymphoblastoid cell lines established from nasopharyngeal carcinoma patients and healthy carriers in Hong Kong","volume":"52","author":"Lung, M.L.; Lam, W.P.; Chan, K.H.","year":"1992","unstructured":"Lung ML, Lam WP, Chan KH, et al. Direct detection of Epstein-Barr virus in peripheral blood and comparison of EBV genotype present in direct specimens and lymphoblastoid cell lines established from nasopharyngeal carcinoma patients and healthy carriers in Hong Kong. Int J Cancer 1992;52:174\u20137.","journal-title":"Int J Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1002\/j.1460-2075.1996.tb00674.x","article-title":"Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice","volume":"15","author":"Wilson, J.B.; Bell, J.L.; Levine, A.J.","year":"1996","unstructured":"Wilson JB, Bell JL, Levine AJ. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J 1996;15:3117\u201326.","journal-title":"EMBO J"},{"key":"ref_27","first-page":"377","article-title":"Molecular epidemiology of Burkitt\u2019s lymphoma","volume":"225","author":"Magrath, I.; Jain, V.; Bhatia, K.","year":"1993","unstructured":"Magrath I, Jain V, Bhatia K. Molecular epidemiology of Burkitt\u2019s lymphoma. The Epstein-Barr Virus and Associated Diseases 1993;225:377.","journal-title":"The Epstein-Barr Virus and Associated Diseases"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/JVI.64.5.2126-2134.1990","article-title":"Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein","volume":"64","author":"Abbot, S.D.; Rowe, M.; Cadwallader, K.","year":"1990","unstructured":"Abbot SD, Rowe M, Cadwallader K, et al. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. J Virol 1990;64: 2126\u201334.","journal-title":"J Virol"},{"key":"ref_29","first-page":"3452","article-title":"Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell","volume-title":"activation antigen CD23. Proc Natl Acad Sci","volume":"83","author":"Wang, F.; Gregory, C.D.; Rowe, M.","year":"1987","unstructured":"Wang F, Gregory CD, Rowe M, et al. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci USA 1987;83:3452\u20137."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1128\/JVI.64.7.3407-3416.1990","article-title":"Epstein-Barr virus nuclear antigen 2 transactivates the latent membrane protein (LMP1)","volume":"64","author":"Wang, F.; Tsang, S.; Kurila, M.","year":"1990","unstructured":"Wang F, Tsang S, Kurila M, et al. Epstein-Barr virus nuclear antigen 2 transactivates the latent membrane protein (LMP1). J Virol 1990;64:3407\u201316.","journal-title":"J Virol"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/JVI.65.1.415-423.1991","article-title":"EpsteinBarr virus nuclear antigen 2 activates transcription of the terminal protein gene","volume":"65","author":"Zimber-Strobl, U.; Suentzenich, K.O.; Laux, G.","year":"1991","unstructured":"Zimber-Strobl U, Suentzenich KO, Laux G, et al. EpsteinBarr virus nuclear antigen 2 activates transcription of the terminal protein gene. J Virol 1991;65:415\u201323.","journal-title":"J Virol"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/JVI.66.5.2893-2903.1992","article-title":"Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in-vitro","volume":"66","author":"Tomkinson, B.; KieV, E.","year":"1992","unstructured":"Tomkinson B, KieV E. Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in-vitro. J Virol 1992;66:2893\u2013903.","journal-title":"J Virol"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/JVI.67.4.2014-2025.1993","article-title":"Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation","volume":"67","author":"Tomkinson, B.; Robertson, E.; KieV, E.","year":"1993","unstructured":"Tomkinson B, Robertson E, KieV, E. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 1993;67: 2014\u201325.","journal-title":"J Virol"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1128\/JVI.64.5.2309-2318.1990","article-title":"Epstein-Barr virus latent membrane protein 1 (LMP1) and nuclear proteins 2 and 3C are eVectors of phenotypic changes in B-lymphocytes: EBNA2 and LMP1 cooperatively induce CD23","volume":"64","author":"Wang, F.; Gregory, C.; Sample, C.","year":"1990","unstructured":"Wang F, Gregory C, Sample C, et al. Epstein-Barr virus latent membrane protein 1 (LMP1) and nuclear proteins 2 and 3C are eVectors of phenotypic changes in B-lymphocytes: EBNA2 and LMP1 cooperatively induce CD23. J Virol 1990;64:2309\u201318.","journal-title":"J Virol"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1006\/viro.1994.1687","article-title":"The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2 mediated transactivation of the viral terminal protein 1 gene promoter","volume":"205","author":"A, Le Roux; B, Kerdiles; D, Walls","year":"1994","unstructured":"Le Roux A, Kerdiles B, Walls D, et al. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2 mediated transactivation of the viral terminal protein 1 gene promoter. Virology 1994;205:596\u2013 602.","journal-title":"Virology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.66.8.4654-4661.1992","article-title":"The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated","volume":"66","author":"Sample, J.; Henson, E.B.; Sample, C.","year":"1992","unstructured":"Sample J, Henson EB, Sample C. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J Virol 1992;66:4654\u201361.","journal-title":"J Virol"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1128\/JVI.65.12.6826-6837.1991","article-title":"The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation","volume":"65","author":"Mannick, J.B.; Cohen, J.I.; Birkenbach, M.","year":"1991","unstructured":"Mannick JB, Cohen JI, Birkenbach M, et al. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J Virol 1991;65:6826\u201337.","journal-title":"J Virol"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1002\/j.1460-2075.1994.tb06634.x","article-title":"EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus","volume":"13","author":"Sinclair, A.J.; Palermo, I.; Peters, G.","year":"1994","unstructured":"Sinclair AJ, Palermo I, Peters G, et al. EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J 1994;13:3321\u20138.","journal-title":"EMBO J"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1101\/gad.10.8.963","article-title":"TANK, a co-inducer with TRAF2 of TNF-and CD40L-mediated NF-B activation","volume":"10","author":"Cheng, G.; Baltimore, D.","year":"1996","unstructured":"Cheng G, Baltimore D. TANK, a co-inducer with TRAF2 of TNF-and CD40L-mediated NF-B activation. Genes Dev 1996;10:963\u201373.","journal-title":"Genes Dev"},{"key":"ref_40","first-page":"5455","article-title":"EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma","volume-title":"and p53 proteins. Proc Natl Acad Sci USA","volume":"90","author":"Szekely, L.; Selivanova, G.; Magnusson, K.P.","year":"1993","unstructured":"Szekely L, Selivanova G, Magnusson KP, et al. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci USA 1993;90:5455\u20139."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0092-8674(85)90256-9","article-title":"An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells","volume":"34","author":"Wang, D.; Liebowitz, D.; KieV, E.","year":"1985","unstructured":"Wang D, Liebowitz D, KieV E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985;34:831\u201340.","journal-title":"Cell"},{"key":"ref_42","first-page":"461","article-title":"Transformation of Balb\/3T3 cells by the BNLF-1 gene of Epstein-Barr virus","volume":"2","author":"Baichwal, V.R.; Sugden, B.","year":"1988","unstructured":"Baichwal VR, Sugden B. Transformation of Balb\/3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene 1988; 2:461\u20137.","journal-title":"Oncogene"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/349612a0","article-title":"Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis","volume":"349","author":"Gregory, C.D.; Dive, C.; Henderson, S.","year":"1991","unstructured":"Gregory CD, Dive C, Henderson S, et al. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 1991;349:612\u201314.","journal-title":"Nature"},{"key":"ref_44","first-page":"1071","article-title":"Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein protects infected B cells from programmed cell death","volume":"65","author":"Henderson, S.; Rowe, M.; Gregory, C.","year":"1991","unstructured":"Henderson S, Rowe M, Gregory C, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein protects infected B cells from programmed cell death. Cell 1991;65:1071\u2013115.","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"24157","DOI":"10.1016\/S0021-9258(18)35741-7","article-title":"The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor B","volume":"267","author":"Laherty, C.D.; Hu, M.M.; Opipari, A.W.","year":"1992","unstructured":"Laherty CD, Hu MM, Opipari AW, et al. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor B. J Biol Chem 1992;267:24157\u201360.","journal-title":"J Biol Chem"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1038\/sj.onc.1201258","article-title":"Epstein-Barr virus encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-B pathway involving TNFreceptor-associated factors","volume":"14","author":"Eliopoulos, A.G.; Stack, M.; Dawson, C.W.","year":"1997","unstructured":"Eliopoulos AG, Stack M, Dawson CW, et al. Epstein-Barr virus encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-B pathway involving TNFreceptor-associated factors. Oncogene 1997;14:2899\u201316.","journal-title":"Oncogene"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ijc.2910570218","article-title":"The EpsteinBarr-virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt-lymphoma lines","volume":"57","author":"Nakagomi, H.; Dolcetti, R.; Bejarano, M.T.","year":"1994","unstructured":"Nakagomi H, Dolcetti R, Bejarano MT, et al. The EpsteinBarr-virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt-lymphoma lines. Int J Cancer 1994;57:240\u20134.","journal-title":"Int J Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/0092-8674(90)90695-B","article-title":"Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6","volume":"61","author":"Wilson, J.B.; Weinberg, W.; Johnson, R.","year":"1990","unstructured":"Wilson JB, Weinberg W, Johnson R, et al. Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 1990;61:1315\u201327.","journal-title":"Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/345447a0","article-title":"Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus","volume":"345","author":"Fahraeus, R.; Rymo, L.; Rhim, J.S.","year":"1990","unstructured":"Fahraeus R, Rymo L, Rhim JS, et al. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 1990;345:447\u20139.","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/344777a0","article-title":"Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation","volume":"344","author":"Dawson, C.W.; Rickinson, A.B.; Young, L.S.","year":"1990","unstructured":"Dawson CW, Rickinson AB, Young LS. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 1990;344:777\u201380.","journal-title":"Nature"},{"key":"ref_51","first-page":"549","article-title":"The Epstein-Barr virus latent membrane protein (LMP1) mediates activation of NF-B and cell surface phenotype via two eVector regions in its carboxyl-terminal cytoplasmic domain","volume":"10","author":"Huen, D.S.; Henderson, S.H.; Croom-Carter, D.","year":"1995","unstructured":"Huen DS, Henderson SH, Croom-Carter D, et al. The Epstein-Barr virus latent membrane protein (LMP1) mediates activation of NF-B and cell surface phenotype via two eVector regions in its carboxyl-terminal cytoplasmic domain. Oncogene 1995;10:549\u201360.","journal-title":"Oncogene"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/sj.onc.1201694","article-title":"Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus encoded latent membrane protein-1","volume":"16","author":"Eliopoulos, A.G.; Young, L.S.","year":"1998","unstructured":"Eliopoulos AG, Young LS. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus encoded latent membrane protein-1. Oncogene 1998; 16:1731\u201342.","journal-title":"Oncogene"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"16085","DOI":"10.1074\/jbc.274.23.16085","article-title":"Activation of the p38 mitogen activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production","volume":"274","author":"Eliopoulos, A.G.; Gallagher, N.J.; Blake, S.M.S.","year":"1999","unstructured":"Eliopoulos AG, Gallagher NJ, Blake SMS, et al. Activation of the p38 mitogen activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J Biol Chem 1999;274:16085\u201396.","journal-title":"J Biol Chem"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1093\/emboj\/18.11.3064","article-title":"Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins","volume":"18","author":"Gires, O.; Kohlhuber, F.; Kilger, E.","year":"1999","unstructured":"Gires O, Kohlhuber F, Kilger E, et al. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J 1999;18:3064\u201373.","journal-title":"EMBO J"},{"key":"ref_55","first-page":"12592","article-title":"The Epstein-Barr virus oncogenic product latent membrane protein 1 engages the tumour necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation","volume-title":"and activate NF-B. Proc Natl Acad Sci","volume":"94","author":"Izumi, K.M.; KieV, E.D.","year":"1997","unstructured":"Izumi KM, KieV ED. The Epstein-Barr virus oncogenic product latent membrane protein 1 engages the tumour necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-B. Proc Natl Acad Sci USA 1997;94:12592\u20137."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1128\/JVI.69.2.675-683.1995","article-title":"The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation: fibroblast cocultivation complements a critical function within the terminal 155 residues","volume":"69","author":"Kaye, K.M.; Izumi, K.M.; Mosialos, G.","year":"1995","unstructured":"Kaye KM, Izumi KM, Mosialos G, et al. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation: fibroblast cocultivation complements a critical function within the terminal 155 residues. J Virol 1995;69:675\u201383.","journal-title":"J Virol"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood.V82.10.2937.2937","article-title":"Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin\u2019s disease and identical to those observed in nasopharyngeal carcinoma","volume":"82","author":"Knecht, H.; Bachmann, E.; Brousset, P.","year":"1993","unstructured":"Knecht H, Bachmann E, Brousset P, et al. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin\u2019s disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993;82:2937\u201342.","journal-title":"Blood"},{"key":"ref_58","first-page":"2129","article-title":"EVect of a 10 amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus","volume":"12","author":"Li, S.N.; Chang, Y.S.; Liu, S.T.","year":"1996","unstructured":"Li SN, Chang YS, Liu ST. EVect of a 10 amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 1996;12:2129\u201335.","journal-title":"Oncogene"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1128\/MCB.16.12.7098","article-title":"TRAF1, TRAF2, and TRAF3 eVect NF-B activation by an Epstein-Barr virus LMP1 domain important for B lymphocyte transformation","volume":"16","author":"Devergne, O.; Hatzivassiliou, E.; Izumi, K.M.","year":"1996","unstructured":"Devergne O, Hatzivassiliou E, Izumi KM, et al. TRAF1, TRAF2, and TRAF3 eVect NF-B activation by an Epstein-Barr virus LMP1 domain important for B lymphocyte transformation. Mol Cell Biol 1996;16:7098\u2013 108.","journal-title":"Mol Cell Biol"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0092-8674(95)90489-1","article-title":"The Epstein-Barr virus transforming protein LMP1 engages signalling proteins for the tumour necrosis factor receptor family","volume":"80","author":"Mosialos, G.; Birkenbach, M.; Yalamanchili, R.","year":"1995","unstructured":"Mosialos G, Birkenbach M, Yalamanchili R, et al. The Epstein-Barr virus transforming protein LMP1 engages signalling proteins for the tumour necrosis factor receptor family. Cell 1995;80:389\u201399.","journal-title":"Cell"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1128\/JVI.71.6.4649-4656.1997","volume":"71","author":"Sandberg, M.; Hammerschmidt, W.; Sugden, B.","year":"1997","unstructured":"Sandberg M, Hammerschmidt W, Sugden B. Characterisation of LMP1s association with TRAF1, TRAF2, and TRAF3. J Virol 1997;71:4649\u201356.","journal-title":"J Virol"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1128\/JVI.73.2.1023-1035.1999","article-title":"EpsteinBarr virus-encoded latent membrane protein 1 activates the JNK pathway through it\u2019s extreme C-terminus via a mechanism involving TRADD and TRAF2","volume":"73","author":"Eliopoulos, A.G.; Blake, S.M.S.; Floettmann, J.E.","year":"1999","unstructured":"Eliopoulos AG, Blake SMS, Floettmann JE, et al. EpsteinBarr virus-encoded latent membrane protein 1 activates the JNK pathway through it\u2019s extreme C-terminus via a mechanism involving TRADD and TRAF2. J Virol 1999;73:1023\u201335.","journal-title":"J Virol"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.immunol.16.1.293","article-title":"JAKS and STATS: biological implications","volume":"16","author":"Leonard, W.J.; O\u2019Shea, J.J.","year":"1998","unstructured":"Leonard WJ, O\u2019Shea JJ. JAKS and STATS: biological implications. Annu Rev Immunol 1998;16:293\u2013322.","journal-title":"Annu Rev Immunol"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1093\/emboj\/16.20.6131","article-title":"Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule","volume":"16","author":"Gires, O.; Zimber-Strobl, U.; Gonnella, R.","year":"1997","unstructured":"Gires O, Zimber-Strobl U, Gonnella R, et al. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J 1997;16:6131\u2013 40.","journal-title":"EMBO J"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/sj.onc.1201359","article-title":"Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-B activation","volume":"15","author":"Floettmann, J.E.; Rowe, M.","year":"1997","unstructured":"Floettmann JE, Rowe M. Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-B activation. Oncogene 1997;15:1851\u20138.","journal-title":"Oncogene"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4049\/jimmunol.160.3.1116","article-title":"A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor B, and stress activated protein kinase","volume":"3","author":"Hatzivassilou, E.; Miller, W.E.; Raab-Traub, N.","year":"1998","unstructured":"Hatzivassilou E, Miller WE, Raab-Traub N, et al. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor B, and stress activated protein kinase. J Immunol 1998;3:1116\u201321.","journal-title":"J Immunol"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1128\/JVI.64.5.2319-2326.1990","article-title":"A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and co-localises with LMP1","volume":"64","author":"Longnecker, R.; KieV, E.","year":"1990","unstructured":"Longnecker R, KieV E. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and co-localises with LMP1. J Virol 1990;64:2319\u201326.","journal-title":"J Virol"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/viro.1997.8690","article-title":"The immunoreceptor tyrosinebased activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR mediated signal transduction","volume":"235","author":"Fruehling, S.; Longnecker, R.","year":"1997","unstructured":"Fruehling S, Longnecker R. The immunoreceptor tyrosinebased activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR mediated signal transduction. Virology 1997;235:241\u201351.","journal-title":"Virology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1074-7613(95)80040-9","article-title":"Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative eVects on proteintyrosine kinases","volume":"2","author":"Miller, C.L.; Burkhardt, A.L.; Lee, J.H.","year":"1995","unstructured":"Miller CL, Burkhardt AL, Lee JH, et al. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative eVects on proteintyrosine kinases. Immunity 1995;2:155\u201366.","journal-title":"Immunity"},{"key":"ref_70","first-page":"128","article-title":"Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sLg-mediated signal transduction","volume":"3","author":"Miller, C.L.; Lee, J.H.; KieV, E.","year":"1994","unstructured":"Miller CL, Lee JH, KieV E, et al. Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sLg-mediated signal transduction. Infect Agents Dis 1994;3:128\u201336.","journal-title":"Infect Agents Dis"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1099\/0022-1317-77-11-2807","article-title":"The latent membrane protein 2 gene of Epstein-Barr virus is important for eYcient B cell immortalization","volume":"77","author":"Brielmeier, M.; Mautner, J.; Laux, G.","year":"1996","unstructured":"Brielmeier M, Mautner J, Laux G, et al. The latent membrane protein 2 gene of Epstein-Barr virus is important for eYcient B cell immortalization. J Gen Virol 1996;77:2807\u201318","journal-title":"J Gen Virol"},{"key":"ref_72","first-page":"1546","article-title":"Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes","volume-title":"and replicates in-vitro. Proc Natl Acad Sci","volume":"88","author":"Swaminathan, S.; Tomkinson, B.; KieV, E.","year":"1991","unstructured":"Swaminathan S, Tomkinson B, KieV E. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in-vitro. Proc Natl Acad Sci USA 1991;88:1546\u201350."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/nar\/19.2.243","article-title":"Binding of Epstein-Barr virus small RNA EBER-1 to the doublestranded RNA-activated protein kinase DAI","volume":"19","author":"Clarke, P.A.; Schwemmie, M.; Schickinger, J.","year":"1991","unstructured":"Clarke PA, Schwemmie M, Schickinger J, et al. Binding of Epstein-Barr virus small RNA EBER-1 to the doublestranded RNA-activated protein kinase DAI. Nucleic Acids Res 1991;19:243\u20138.","journal-title":"Nucleic Acids Res"},{"key":"ref_74","first-page":"107","article-title":"Functional significance of the Epstein-Barr virus-encoded small RNAs","volume":"5","author":"Clemens, M.J.","year":"1994","unstructured":"Clemens MJ. Functional significance of the Epstein-Barr virus-encoded small RNAs. EBV Report 1994;5:107\u201311.","journal-title":"EBV Report"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1073\/pnas.78.2.805","article-title":"Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with lupus erythematosus","volume":"78","author":"Lerner, M.R.; Andrews, N.C.; Miller, G.","year":"1981","unstructured":"Lerner MR, Andrews NC, Miller G, et al. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with lupus erythematosus. Proc Natl Acad Sci USA 1981;78:805\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref_76","first-page":"3463","article-title":"The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalises ribosomal protein L22","volume-title":"EBV infected human B-lymphocytes. Proc Natl Acad Sci USA","volume":"91","author":"Toczyski, D.P.; Matera, A.G.; Ward, D.C.","year":"1994","unstructured":"Toczyski DP, Matera AG, Ward DC, et al. The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalises ribosomal protein L22 in EBV infected human B-lymphocytes. Proc Natl Acad Sci USA 1994;91:3463\u20137."},{"key":"ref_77","first-page":"4789","article-title":"Two small RNAs encoded by Epstein-Barr virus can functionally substitute for the virusassociated RNAs in the lytic growth","volume-title":"of adenovirus 5. Proc Natl Acad Sci","volume":"80","author":"Bhat, R.A.; Thimmappaya, B.","year":"1983","unstructured":"Bhat RA, Thimmappaya B. Two small RNAs encoded by Epstein-Barr virus can functionally substitute for the virusassociated RNAs in the lytic growth of adenovirus 5. Proc Natl Acad Sci USA 1983;80:4789\u201393."},{"key":"ref_78","first-page":"86","article-title":"Epstein-Barr viral DNA in tissues of Hodgkin\u2019s disease","volume":"129","author":"Weiss, L.M.; Strickler, J.G.; Warnke, R.A.","year":"1987","unstructured":"Weiss LM, Strickler JG, Warnke RA, et al. Epstein-Barr viral DNA in tissues of Hodgkin\u2019s disease. Am J Pathol 1987;129:86\u201391.","journal-title":"Am J Pathol"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ajcp\/91.1.1","article-title":"A survey of Epstein-Barr virus DNA in lymphoid tissue: frequent detection in Hodgkin\u2019s disease","volume":"91","author":"Staal, S.P.; Ambinder, R.; Beschorner, W.E.","year":"1989","unstructured":"Staal SP, Ambinder R, Beschorner WE, et al. A survey of Epstein-Barr virus DNA in lymphoid tissue: frequent detection in Hodgkin\u2019s disease. Am J Clin Pathol 1989;91: 1\u20135.","journal-title":"Am J Clin Pathol"},{"key":"ref_80","first-page":"13","article-title":"High incidence of Epstein-Barr virus genomes in Hodgkin\u2019s disease","volume":"137","author":"Herbst, H.; Niedobitek, G.; Kneba, M.","year":"1990","unstructured":"Herbst H, Niedobitek G, Kneba M, et al. High incidence of Epstein-Barr virus genomes in Hodgkin\u2019s disease. Am J Pathol 1990;137:13\u201318.","journal-title":"Am J Pathol"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ijc.2910460509","article-title":"Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin\u2019s disease","volume":"46","author":"Wu, T.C.; Mann, R.B.; Charache, P.","year":"1990","unstructured":"Wu TC, Mann RB, Charache P, et al. Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin\u2019s disease. Int J Cancer 1990;46:801\u20134.","journal-title":"Int J Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/mcpr.1993.1014","article-title":"Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection","author":"Barletta, J.M.; Kingma, D.W.; Charache, P.","year":"1993","unstructured":"Barletta JM, Kingma DW, Charache P, et al. Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection. Mol Cell Probes 1993:7;105\u20139.","journal-title":"Mol Cell Probes"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0140-6736(91)90943-J","article-title":"Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin\u2019s disease","volume":"337","author":"Pallesen, G.; Hamilton-Dutoit, S.J.; Rowe, M.","year":"1991","unstructured":"Pallesen G, Hamilton-Dutoit SJ, Rowe M, et al. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin\u2019s disease. Lancet 1991;337:320\u20132.","journal-title":"Lancet"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1711660102","article-title":"Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraYn sections of Hodgkin\u2019s disease","volume":"166","author":"Murray, P.G.; Young, L.S.; Rowe, M.","year":"1992","unstructured":"Murray PG, Young LS, Rowe M, et al. Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraYn sections of Hodgkin\u2019s disease. J Pathol 1992;166:1\u20135.","journal-title":"J Pathol"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/jcp.50.11.911","article-title":"Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas","volume":"50","author":"Brink, A.A.; Dukers, D.F.; van den Brule, A.J.","year":"1997","unstructured":"Brink AA, Dukers DF, van den Brule AJ, et al. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas. J Clin Pathol 1997;50:911\u201318.","journal-title":"J Clin Pathol"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1182\/blood.V84.11.3792.bloodjournal84113792","article-title":"Monoclonal antibodies directed against the Epstein-Barr virus encoded nuclear antigen 1: immmunohistological detection of EBNA1 in the malignant cells of Hodgkin\u2019s disease","volume":"84","author":"Grasser, F.; Murray, P.G.; Kremmer, E.","year":"1994","unstructured":"Grasser F, Murray PG, Kremmer E, et al. Monoclonal antibodies directed against the Epstein-Barr virus encoded nuclear antigen 1: immmunohistological detection of EBNA1 in the malignant cells of Hodgkin\u2019s disease. Blood 1994;84:3792\u22128.","journal-title":"Blood"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1096-9896(199601)178:1<44::AID-PATH471>3.0.CO;2-0","article-title":"In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas","volume":"178","author":"Murray, P.G.; Niedobitek, G.; Kremmer, E.","year":"1996","unstructured":"Murray PG, Niedobitek G, Kremmer E, et al. In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas. J Pathol 1996;178:44\u20137.","journal-title":"J Pathol"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood.V90.4.1664","article-title":"Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin\u2019s disease and infectious mononucleosis","volume":"90","author":"Niedobitek, G.; Kremmer, E.; Herbst, H.","year":"1997","unstructured":"Niedobitek G, Kremmer E, Herbst H, et al. Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin\u2019s disease and infectious mononucleosis. Blood 1997;90:1664\u201372.","journal-title":"Blood"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1182\/blood.V92.7.2477","article-title":"Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin\u2019s disease. Immunity to EBV in healthy virus carriers","volume":"92","author":"Murray, P.G.; Constandinou, C.M.; Crocker, J.","year":"1998","unstructured":"Murray PG, Constandinou CM, Crocker J, et al. Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin\u2019s disease. Immunity to EBV in healthy virus carriers. Blood 1998;92:2477\u201383.","journal-title":"Blood"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.169.3941.188","article-title":"DiVerential reactivity of human serums with early antigens induced by Epstein-Barr virus","volume":"169","author":"Henle, W.; Henle, G.; Zajac, B.A.","year":"1970","unstructured":"Henle W, Henle G, Zajac BA, et al. DiVerential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science 1970;169:188\u201390.","journal-title":"Science"},{"key":"ref_91","first-page":"97","article-title":"Immune surveillance against Epstein-Barr virus. Semin lmmunol","volume":"4","author":"Moss, D.J.; Burrows, SR, Khanna; R.","year":"1992","unstructured":"Moss DJ, Burrows SR, Khanna R, et al. Immune surveillance against Epstein-Barr virus. Semin lmmunol 1992;4:97\u2013104."},{"key":"ref_92","first-page":"1153","article-title":"Thymic origin of atypical lymphoid cells in IM","volume":"I:","author":"Sheldon, P.J.; Papamichail, M.; Hemsted, E.H.","year":"1973","unstructured":"Sheldon PJ, Papamichail M, Hemsted EH, et al. Thymic origin of atypical lymphoid cells in IM. Lancet 1973;I: 1153\u20135.","journal-title":"Lancet"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ijc.2910220604","article-title":"Long-term T cell mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes","volume":"22","author":"Moss, D.J.; Rickinson, A.B.; Pope, J.H.","year":"1978","unstructured":"Moss DJ, Rickinson AB, Pope JH. Long-term T cell mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer 1978;22:662\u20138.","journal-title":"Int J Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ijc.2910230506","article-title":"Long-term T cell mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leucocyte cultures","volume":"23","author":"Moss, D.J.; Rickinson, A.B.; Pope, J.H.","year":"1979","unstructured":"Moss DJ, Rickinson AB, Pope JH. Long-term T cell mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leucocyte cultures. Int J Cancer 1979;23:618\u201325.","journal-title":"Int J Cancer"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0008-8749(91)90029-B","article-title":"Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4+ cytotoxic T cell clones and includes an Epstein-Barr virus-specific component","volume":"132","author":"Misko, I.S.; Sculley, T.B.; Schmidt, C.","year":"1991","unstructured":"Misko IS, Sculley TB, Schmidt C, et al. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4+ cytotoxic T cell clones and includes an Epstein-Barr virus-specific component. Cell Immunol 1991;132:295\u2013307.","journal-title":"Cell Immunol"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1128\/JVI.67.3.1572-1578.1993","article-title":"Multiple HLA A11 restricted CTL epitopes of diVerent immunogenicities in the Epstein-Barr virus encoded nuclear antigen-4 (EBNA4)","volume":"67","author":"Gavioli, R.; Kurilla, M.; de Campos-Lima, P.O.","year":"1993","unstructured":"Gavioli R, Kurilla M, de Campos-Lima PO, et al. Multiple HLA A11 restricted CTL epitopes of diVerent immunogenicities in the Epstein-Barr virus encoded nuclear antigen-4 (EBNA4). J Virol 1993;67:1572\u20138.","journal-title":"J Virol"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.183.3.915","article-title":"The life span of major histocompatibility complex\u2013peptide complexes influences the eYciency of presentation and immunogenicity of two class I-restricted cytotoxic T-lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4","volume":"183","author":"Levitsky, V.; Zhang, Q.J.; Levitskaya, J.","year":"1996","unstructured":"Levitsky V, Zhang QJ, Levitskaya J, et al. The life span of major histocompatibility complex\u2013peptide complexes influences the eYciency of presentation and immunogenicity of two class I-restricted cytotoxic T-lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J Exp Med 1996; 183:915\u201326.","journal-title":"J Exp Med"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.7682013","article-title":"HLA-A 11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population","volume":"260","author":"de Campos-Lima PO; R, Gavioli; QJ, Zhang","year":"1993","unstructured":"de Campos-Lima PO, Gavioli R, Zhang QJ, et al. HLA-A 11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science 1993;260:98\u2013100.","journal-title":"Science"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1084\/jem.179.4.1297","article-title":"T cell responses and virus evolution: Epstein-Barr virus isolates from highly HLA A11-positive populations carry mutations selectively involving anchor residues of A11-restricted CTL epitopes","volume":"179","author":"de Campos-Lima PO; V, Levitsky; J, Brooks","year":"1994","unstructured":"de Campos-Lima PO, Levitsky V, Brooks J, et al. T cell responses and virus evolution: Epstein-Barr virus isolates from highly HLA A11-positive populations carry mutations selectively involving anchor residues of A11-restricted CTL epitopes. J Exp Med 1994;179:1297\u2013305.","journal-title":"J Exp Med"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ijc.2910480527","article-title":"The EpsteinBarr virus encoded membrane protein LMP but not the nuclear antigen EBNA-1 induces rejection of transfected murine mammary carcinoma cells","volume":"48","author":"Trivedi, P.; Masucci, M.G.; Winberg, G.","year":"1991","unstructured":"Trivedi P, Masucci MG, Winberg G, et al. The EpsteinBarr virus encoded membrane protein LMP but not the nuclear antigen EBNA-1 induces rejection of transfected murine mammary carcinoma cells. Int J Cancer 1991;48: 794\u2013800.","journal-title":"Int J Cancer"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1006\/viro.1995.0076","article-title":"Isolation of cytotoxic T-lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance","volume":"214","author":"Khanna, R.; Burrows, SR, Steigerwald-Mullen; P.M.","year":"1995","unstructured":"Khanna R, Burrows SR, Steigerwald-Mullen PM, et al. Isolation of cytotoxic T-lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance. Virology 1995;214: 633\u20137.","journal-title":"Virology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/375685a0","article-title":"Inhibition of antigen processing by the internal repeat region of the EpsteinBarr virus nuclear antigen-1","volume":"375","author":"Levitskaya, J.; Coram, M.; Levitsky, V.","year":"1995","unstructured":"Levitskaya J, Coram M, Levitsky V, et al. Inhibition of antigen processing by the internal repeat region of the EpsteinBarr virus nuclear antigen-1. Nature 1995;375:685\u20138.","journal-title":"Nature"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1128\/JVI.67.12.7428-7435.1993","article-title":"HLA A2.1 restricted cytotoxic T cells recognizing a range of EpsteinBarr virus isolates through a defined epitope in latent membrane protein LMP2","volume":"67","author":"Lee, S.P.; Thomas, W.A.; Murray, R.J.","year":"1993","unstructured":"Lee SP, Thomas WA, Murray RJ, et al. HLA A2.1 restricted cytotoxic T cells recognizing a range of EpsteinBarr virus isolates through a defined epitope in latent membrane protein LMP2. J Virol 1993;67:7428\u201335.","journal-title":"J Virol"},{"key":"ref_104","article-title":"Isolation of EpsteinBarr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: implications for immune-mediated therapy for Hodgkin\u2019s disease","volume":"89","author":"Sing, A.; Ambinder, R.F.; Hong, D.J.","year":"1997","unstructured":"Sing A, Ambinder RF, Hong DJ, et al. Isolation of EpsteinBarr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: implications for immune-mediated therapy for Hodgkin\u2019s disease. Blood 1997;89:1978.","journal-title":"Blood"},{"key":"ref_105","first-page":"173","article-title":"The pathology of post transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression","volume":"133","author":"Nalesnik, M.A.; JaVe, R.; Starzl","year":"1988","unstructured":"Nalesnik MA, JaVe R, Starzl, et al. The pathology of post transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988;133:173\u201392.","journal-title":"Am J Pathol"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1182\/blood.V72.2.520.520","article-title":"Epstein-Barr virus lymphoproliferation after bone marrow transplantation","volume":"72","author":"Zutter, M.M.; Martin, P.J.; Sale, G.E.","year":"1988","unstructured":"Zutter MM, Martin PJ, Sale GE, et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 1988;72:520\u20139.","journal-title":"Blood"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJM198909213211203","article-title":"Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia","volume":"321","author":"Withersponn, R.P.; Fisher, L.D.; Schoch, G.","year":"1989","unstructured":"Withersponn RP, Fisher LD, Schoch G, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989;321:784\u20139.","journal-title":"N Engl J Med"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0140-6736(80)91800-0","article-title":"Epstein-Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patients with renal allograft","volume":"I:","author":"Crawford, D.H.; Thomas, J.A.; Janossy, G.","year":"1980","unstructured":"Crawford DH, Thomas JA, Janossy G, et al. Epstein-Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patients with renal allograft. Lancet 1980;I: 1355\u20136.","journal-title":"Lancet"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation","volume":"345","author":"Rooney, C.M.; Smith, C.A.; Ng, C.Y.C.","year":"1995","unstructured":"Rooney CM, Smith CA, Ng CYC, et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 1995;345:9\u201313.","journal-title":"Lancet"},{"key":"ref_110","first-page":"679","article-title":"Infusion of donor leukocytes to treat Epstein-Barr virus associated lymphoproliferative disorders after allogeneic bone marrow transplantation","volume":"331","author":"Papadopoulos, E.B.; Ladanyi, M.; Emanuel, D.","year":"1994","unstructured":"Papadopoulos EB, Ladanyi M, Emanuel D, et al. Infusion of donor leukocytes to treat Epstein-Barr virus associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994;331:679\u201380.","journal-title":"N Engl J Med"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","article-title":"Long term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes","volume":"2","author":"Heslop, H.E.; Ng, C.Y.C.; Smith, C.A.","year":"1996","unstructured":"Heslop HE, Ng CYC, Smith CA, et al. Long term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med 1996;2:551\u20135.","journal-title":"Nat Med"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1056\/NEJM198910193211604","article-title":"Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease","volume":"321","author":"Young, L.; Alfieri, C.; Hennessy, K.","year":"1989","unstructured":"Young L, Alfieri C, Hennessy K, et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 1989;321:1080\u20135.","journal-title":"N Engl J Med"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1182\/blood.V81.5.1393.1393","article-title":"Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders","volume":"81","author":"Cen, H.; Williams, P.A.; McWilliams, H.P.","year":"1993","unstructured":"Cen H, Williams PA, McWilliams HP, et al. Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders. Blood 1993;81:1393\u2013403.","journal-title":"Blood"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood.V87.2.706.bloodjournal872706","article-title":"bcl-2 but not the EBV-encoded bcl-2 homologue, BHRF1, is commonly expressed in post-transplantation lymphoproliferative disorders","volume":"87","author":"Murray, P.G.; Swinnen, L.J.; Constandinou, C.M.","year":"1996","unstructured":"Murray PG, Swinnen LJ, Constandinou CM, et al. bcl-2 but not the EBV-encoded bcl-2 homologue, BHRF1, is commonly expressed in post-transplantation lymphoproliferative disorders. Blood 1996;87:706\u201311.","journal-title":"Blood"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/blood.V85.2.552.552","article-title":"Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders","volume":"85","author":"Knowles, D.M.; Cesarman, E.; Chadburn, A.","year":"1995","unstructured":"Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995;85:552\u221265.","journal-title":"Blood"},{"key":"ref_116","first-page":"10411","article-title":"MYC activation renders proliferation of Epstein-Barr virus (EBV)transformed cells independent of EBV nuclear antigen 2 and latent","volume-title":"membrane protein 1. Proc Natl Acad Sci","volume":"93","author":"Polack, A.; Hortnagel, K.; Pajic, A.","year":"1996","unstructured":"Polack A, Hortnagel K, Pajic A, et al. MYC activation renders proliferation of Epstein-Barr virus (EBV)transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1. Proc Natl Acad Sci USA 1996;93:10411\u221216."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1182\/blood.V92.7.2294","article-title":"BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome","volume":"92","author":"Cesarman, E.; Chadburn, A.; Liu, Y.F.","year":"1998","unstructured":"Cesarman E, Chadburn A, Liu YF, et al. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome. Blood 1998;92:2294\u2212302.","journal-title":"Blood"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199805143382003","article-title":"Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients","volume":"338","author":"Liebowitz, D.","year":"1998","unstructured":"Liebowitz D. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med 1998;338:1413\u221221.","journal-title":"N Engl J Med"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1056\/NEJM199805143382011","article-title":"Epstein-Barr virus in action in vivo","volume":"338","author":"Rickinson, A.B.","year":"1998","unstructured":"Rickinson AB. Epstein-Barr virus in action in vivo. N Engl J Med 1998;338:1461\u22123.","journal-title":"N Engl J Med"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1128\/JVI.65.2.976-980.1991","article-title":"Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4","volume":"65","author":"Cen, H.; Breinig, M.C.; Atchison, R.W.","year":"1991","unstructured":"Cen H, Breinig MC, Atchison RW, et al. Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4. J Virol 1991;65:976\u201380.","journal-title":"J Virol"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/infdis\/152.5.876","article-title":"Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection","volume":"152","author":"Ho, M.; Miller, G.; Atchison, R.W.","year":"1985","unstructured":"Ho M, Miller G, Atchison RW, et al. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis 1985;152:876\u201386.","journal-title":"J Infect Dis"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0140-6736(91)91837-K","article-title":"EpsteinBarr virus in AIDS-related primary central nervous system lymphoma","volume":"338","author":"MacMahon, E.M.E.; Glass, J.D.; Hayward, S.D.","year":"1991","unstructured":"MacMahon EME, Glass JD, Hayward SD, et al. EpsteinBarr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991;338:969\u201373.","journal-title":"Lancet"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1182\/blood.V78.11.3004.3004","article-title":"Subtypes of Epstein-Barr virus in human immunodeficiency virusassociated non-Hodgkin lymphoma","volume":"78","author":"Boyle, M.T.; Sewell, W.A.; Sculley, T.B.","year":"1991","unstructured":"Boyle MT, Sewell WA, Sculley TB, et al. Subtypes of Epstein-Barr virus in human immunodeficiency virusassociated non-Hodgkin lymphoma. Blood 1991;78:3004\u201311.","journal-title":"Blood"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi\u2019s sarcoma associated herpesvirus-like DNA sequences in AIDSrelated body cavity based lymphomas","volume":"332","author":"Cesarman, E.; Chang, Y.I.; Moore, P.S.","year":"1995","unstructured":"Cesarman E, Chang YI, Moore PS, et al. Kaposi\u2019s sarcoma associated herpesvirus-like DNA sequences in AIDSrelated body cavity based lymphomas. N Engl J Med 1995; 332:1186\u201391.","journal-title":"N Engl J Med"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood.V77.7.1527.1527","article-title":"Epstein-Barr virus in benign lymph-node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin\u2019s lymphoma","volume":"77","author":"Shibata, M.; Weiss, L.M.; Nathwani, B.N.","year":"1991","unstructured":"Shibata M, Weiss LM, Nathwani BN, et al. Epstein-Barr virus in benign lymph-node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin\u2019s lymphoma. Blood 1991;77:1527\u201333.","journal-title":"Blood"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1200\/JCO.1993.11.9.1674","article-title":"Human immunodeficiency-virus-associated systemic lymphomas may be subdivided into two main types according to Epstein-Barr virus gene expression","volume":"11","author":"Carbone, A.; Tirelli, U.; Gloghini, A.","year":"1993","unstructured":"Carbone A, Tirelli U, Gloghini A, et al. Human immunodeficiency-virus-associated systemic lymphomas may be subdivided into two main types according to Epstein-Barr virus gene expression. J Clin Oncol 1993;11: 1674\u201381.","journal-title":"J Clin Oncol"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/infdis\/173.3.529","article-title":"Epstein-Barr virus DNA recombination and loss in sporadic Burkitt\u2019s lymphoma","volume":"173","author":"Razzouk, B.I.; Srinivas, S.; Sample, C.E.","year":"1996","unstructured":"Razzouk BI, Srinivas S, Sample CE, et al. Epstein-Barr virus DNA recombination and loss in sporadic Burkitt\u2019s lymphoma. J Infect Dis 1996;173:529\u201335.","journal-title":"J Infect Dis"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood.V77.7.1516.1516","article-title":"Patterns of chromosomal breakpoint locations in Burkitt\u2019s lymphoma: relevance to geography and Epstein-Barr virus association","volume":"77","author":"Shiramizu, B.; Barriga, F.; Neequaye, J.","year":"1991","unstructured":"Shiramizu B, Barriga F, Neequaye J, et al. Patterns of chromosomal breakpoint locations in Burkitt\u2019s lymphoma: relevance to geography and Epstein-Barr virus association. Blood 1991;77:1516\u201326.","journal-title":"Blood"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0140-6736(91)90203-2","article-title":"Circulating EpsteinBarr virus-carrying B cells in acute malaria","volume":"337","author":"Lam, K.M.C.; Syed, N.; Whittle, H.","year":"1991","unstructured":"Lam KMC, Syed N, Whittle H, et al. Circulating EpsteinBarr virus-carrying B cells in acute malaria. Lancet 1991;337:876\u20138.","journal-title":"Lancet"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1099\/0022-1317-71-7-1481","article-title":"DiVerent EpsteinBarr virus (EBV) B cell interactions in phenotypically distinct clones of a Burkitt lymphoma cell line","volume":"71","author":"Gregory, C.D.; Rowe, D.M.; Rickinson, A.B.","year":"1990","unstructured":"Gregory CD, Rowe DM, Rickinson AB. DiVerent EpsteinBarr virus (EBV) B cell interactions in phenotypically distinct clones of a Burkitt lymphoma cell line. J Gen Virol 1990;71:1481\u201395.","journal-title":"J Gen Virol"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ijc.2910400313","article-title":"Down-regulation of the EBV-encoded membrane protein (LMP) in Burkitt lymphomas","volume":"40","author":"Hatzubai, A.; Anafi, M.; Masucci, M.G.","year":"1987","unstructured":"Hatzubai A, Anafi M, Masucci MG, et al. Down-regulation of the EBV-encoded membrane protein (LMP) in Burkitt lymphomas. Int J Cancer 1987;40:358\u201364.","journal-title":"Int J Cancer"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1002\/j.1460-2075.1987.tb02568.x","article-title":"DiVerences in B cell growth phenotype reflect novel patterns of EpsteinBarr virus latent gene expression in Burkitt\u2019s lymphoma cells","volume":"6","author":"Rowe, M.; Rowe, D.T.; Gregory, C.D.","year":"1987","unstructured":"Rowe M, Rowe DT, Gregory CD, et al. DiVerences in B cell growth phenotype reflect novel patterns of EpsteinBarr virus latent gene expression in Burkitt\u2019s lymphoma cells. EMBO J 1987;6:2743\u201351.","journal-title":"EMBO J"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1182\/blood.V86.2.659.bloodjournal862659","article-title":"Heterogenous expression of Epstein-Barr virus latent proteins in endemic Burkitt\u2019s lymphoma","volume":"86","author":"Niedobitek, G.; Agathanggelou, A.; Rowe, M.","year":"1995","unstructured":"Niedobitek G, Agathanggelou A, Rowe M, et al. Heterogenous expression of Epstein-Barr virus latent proteins in endemic Burkitt\u2019s lymphoma. Blood 1995;86:659\u201365.","journal-title":"Blood"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1182\/blood.V87.3.1202b.bloodjournal8731202b","article-title":"Expression of Epstein-Barr virus encoded latent membrane protein-1 in non-endemic Burkitt\u2019s lymphoma","volume":"87","author":"Carbone, A.; Gloghini, A.","year":"1995","unstructured":"Carbone A, Gloghini A. Expression of Epstein-Barr virus encoded latent membrane protein-1 in non-endemic Burkitt\u2019s lymphoma. Blood 1995;87:1202\u20134.","journal-title":"Blood"},{"key":"ref_135","article-title":"A new look at tumour immunology","author":"McMichael, A.","year":"1992","unstructured":"McMichael A, Bodmer WF, eds. A new look at tumour immunology. New York: CSHL Press, 1992."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ijc.2910530525","article-title":"Antigen processing and presentation by EBV-carrying cell lines: cell-phenotype dependence and influence of the EBV-encoded LMP1","volume":"53","author":"de Campos-Lima PO; S, Torsteinsdottir; L, Cuomo","year":"1993","unstructured":"de Campos-Lima PO, Torsteinsdottir S, Cuomo L, et al. Antigen processing and presentation by EBV-carrying cell lines: cell-phenotype dependence and influence of the EBV-encoded LMP1. Int J Cancer 1993;53:856\u201362.","journal-title":"Int J Cancer"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/intimm\/6.4.639","article-title":"Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restore immunogenicity of an antigen processing defective tumor cell line","volume":"6","author":"Khanna, R.; Burrows, SR, Agaet; V.","year":"1994","unstructured":"Khanna R, Burrows SR, Agaet V, et al. Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restore immunogenicity of an antigen processing defective tumor cell line. Int Immunol 1994;6:639\u201345.","journal-title":"Int Immunol"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0092-8674(87)90556-3","article-title":"Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene in lymphoblasts","volume":"49","author":"Lombardi, L.; Newcomb, E.; Dalla-Favera, R.","year":"1987","unstructured":"Lombardi L, Newcomb E, Dalla-Favera R. Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene in lymphoblasts. Cell 1987;49:161\u201370.","journal-title":"Cell"},{"key":"ref_139","first-page":"10411","article-title":"c-myc activation renders proliferation of Epstein-Barr virus (EBV)transformed cells independent of EBV nuclear antigen 2 and latent","volume-title":"membrane protein 1. Proc Natl Acad Sci","volume":"93","author":"Polack, A.; Hortnagel, K.; Pajic, A.","year":"1996","unstructured":"Polack A, Hortnagel K, Pajic A, et al. c-myc activation renders proliferation of Epstein-Barr virus (EBV)transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1. Proc Natl Acad Sci USA 1996;93:10411\u201316."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1128\/JVI.66.6.3715-3724.1992","article-title":"Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes","volume":"66","author":"Qu, L.; Rowe, D.T.","year":"1992","unstructured":"Qu L, Rowe DT. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J Virol 1992; 66:3715\u201324.","journal-title":"J Virol"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1128\/JVI.68.11.7374-7385.1994","article-title":"Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state","volume":"68","author":"Tierney, R.J.; Steven, N.; Young, L.S.","year":"1994","unstructured":"Tierney RJ, Steven N, Young LS, et al. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 1994;68:7374\u201385.","journal-title":"J Virol"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1128\/JVI.68.9.6069-6073.1994","article-title":"Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt\u2019s lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV","volume":"68","author":"Shimizu, N.; Tanabe-Tochikiura, A.; Kuroiwa, Y.","year":"1994","unstructured":"Shimizu N, Tanabe-Tochikiura A, Kuroiwa Y, et al. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt\u2019s lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol 1994;68:6069\u201373.","journal-title":"J Virol"},{"key":"ref_143","first-page":"92","article-title":"Epidemiology of Hodgkin\u2019s disease","volume":"7","author":"Gutensohn, N.; Cole, P.","year":"1980","unstructured":"Gutensohn N, Cole P. Epidemiology of Hodgkin\u2019s disease. Semin Oncol 1980;7:92\u2013102.","journal-title":"Semin Oncol"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/1097-0142(197102)27:2<416::AID-CNCR2820270227>3.0.CO;2-W","article-title":"Elevated antibody titers to Epstein-Barr virus in Hodgkin\u2019s disease","volume":"27","author":"Levine, P.H.; Ablashi, D.V.; Berard, C.W.","year":"1971","unstructured":"Levine PH, Ablashi DV, Berard CW, et al. Elevated antibody titers to Epstein-Barr virus in Hodgkin\u2019s disease. Cancer 1971;27:416\u201321.","journal-title":"Cancer"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM198903163201103","article-title":"Hodgkin\u2019s disease and Epstein-Barr virus. Altered antibody pattern before diagnosis","volume":"32","author":"Mueller, N.; Evans, A.; Harris, N.L.","year":"1989","unstructured":"Mueller N, Evans A, Harris NL, et al. Hodgkin\u2019s disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 1989;32:689\u201395.","journal-title":"N Engl J Med"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/0959-8049(95)00117-2","article-title":"Case clustering, Epstein-Barr virus Reed-Sternberg cell status and herpes virus serology in Hodgkin\u2019s disease: results of a case control study","volume":"31","author":"Alexander, F.E.; Daniel, C.P.; Armstrong, A.A.","year":"1995","unstructured":"Alexander FE, Daniel CP, Armstrong AA, et al. Case clustering, Epstein-Barr virus Reed-Sternberg cell status and herpes virus serology in Hodgkin\u2019s disease: results of a case control study. Eur J Cancer 1995;31A:1479\u201386.","journal-title":"Eur J Cancer"},{"key":"ref_147","first-page":"86","article-title":"Epstein-Barr viral DNA in tissues of Hodgkin\u2019s disease","volume":"129","author":"Weiss, L.M.; Strickler, J.G.; Warnke, R.A.","year":"1987","unstructured":"Weiss LM, Strickler JG, Warnke RA, et al. Epstein-Barr viral DNA in tissues of Hodgkin\u2019s disease. Am J Pathol 1987;129:86\u201391.","journal-title":"Am J Pathol"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood.V81.2.496.496","article-title":"High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin\u2019s disease occurring in Peru","volume":"81","author":"Chang, K.L.; Albujar, P.F.; Chen, Y.-Y.","year":"1993","unstructured":"Chang KL, Albujar PF, Chen Y-Y, et al. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin\u2019s disease occurring in Peru. Blood 1993;81:496\u2013501.","journal-title":"Blood"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1182\/blood.V87.9.3828.bloodjournal8793828","article-title":"The consistent association between Epstein-Barr virus and Hodgkin\u2019s disease in children in Kenya","volume":"87","author":"Weinreb, M.; Day, P.J.R.; Niggli, F.","year":"1996","unstructured":"Weinreb M, Day PJR, Niggli F, et al. The consistent association between Epstein-Barr virus and Hodgkin\u2019s disease in children in Kenya. Blood 1996;87:3828\u201336.","journal-title":"Blood"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood.V74.2.810.810","article-title":"Demonstration of monoclonal EBV genomes in Hodgkin\u2019s disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization","volume":"74","author":"Anagnostopoulos, I.; Herbst, H.; Niedobitek, G.","year":"1989","unstructured":"Anagnostopoulos I, Herbst H, Niedobitek G, et al. Demonstration of monoclonal EBV genomes in Hodgkin\u2019s disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1989;74:810\u201316.","journal-title":"Blood"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.177.2.339","article-title":"Epstein-Barr virus and Hodgkin\u2019s disease: transcriptional analysis of virus latency in the malignant cells","volume":"177","author":"Deacon, E.M.; Pallesen, G.; Niedobitek, G.","year":"1993","unstructured":"Deacon EM, Pallesen G, Niedobitek G, et al. Epstein-Barr virus and Hodgkin\u2019s disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 1993;177: 339\u201349.","journal-title":"J Exp Med"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/jcp.44.10.844","article-title":"Detection of EBV genomes in Hodgkin\u2019s disease: relation to age","volume":"44","author":"Jarrett, R.F.; Gallagher, A.; Jones, D.B.","year":"1991","unstructured":"Jarrett RF, Gallagher A, Jones DB, et al. Detection of EBV genomes in Hodgkin\u2019s disease: relation to age. J Clin Pathol 1991;44:844\u20138.","journal-title":"J Clin Pathol"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.leu.2401097","article-title":"Epstein-Barr virus and Hodgkin\u2019s disease: further evidence for the three disease hypothesis","volume":"12","author":"Armstrong, A.A.; Alexander, F.E.; Cartwright, R.","year":"1998","unstructured":"Armstrong AA, Alexander FE, Cartwright R, et al. Epstein-Barr virus and Hodgkin\u2019s disease: further evidence for the three disease hypothesis. Leukemia 1998;12: 1272\u20136.","journal-title":"Leukemia"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ijc.2910460405","article-title":"High frequency of Epstein-Barr virus genome detection in Hodgkin\u2019s disease of HIV-positive patients","volume":"46","author":"Uccini, S.; Monardo, F.; Stoppacciaro, A.","year":"1990","unstructured":"Uccini S, Monardo F, Stoppacciaro A, et al. High frequency of Epstein-Barr virus genome detection in Hodgkin\u2019s disease of HIV-positive patients. Int J Cancer 1990;46:581\u20135.","journal-title":"Int J Cancer"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.bjc.6690398","article-title":"EVect of material deprivation on Epstein-Barr virus infection in Hodgkin\u2019s disease in the West Midlands","volume":"80","author":"Flavell, K.; Constandinou, C.; Lowe, D.","year":"1999","unstructured":"Flavell K, Constandinou C, Lowe D, et al. EVect of material deprivation on Epstein-Barr virus infection in Hodgkin\u2019s disease in the West Midlands. Br J Cancer 1999;80: 604\u20138.","journal-title":"Br J Cancer"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1182\/blood.V87.3.1045.bloodjournal8731045","article-title":"Epstein-Barr virus genome in non-Hodgkin\u2019s lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis","volume":"87","author":"d\u2019Amore F; P, Iohansen; A, Houmand","year":"1996","unstructured":"d\u2019Amore F, Iohansen P, Houmand A, et al. Epstein-Barr virus genome in non-Hodgkin\u2019s lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Blood 1996;87:1045\u201355.","journal-title":"Blood"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1182\/blood.V82.3.858.858","article-title":"Association of the subtype 2 of the Epstein-Barr virus with T-cell nonHodgkin lymphoma of the midline granuloma type","volume":"82","author":"Borisch, B.; Hennig, I.; Laeng, R.H.","year":"1993","unstructured":"Borisch B, Hennig I, Laeng RH, et al. Association of the subtype 2 of the Epstein-Barr virus with T-cell nonHodgkin lymphoma of the midline granuloma type. Blood 1993;82:858\u201364.","journal-title":"Blood"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0092-8674(86)90803-2","article-title":"The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation","volume":"47","author":"Raab-Traub, N.; Flynn, K.","year":"1986","unstructured":"Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986;47:883\u20139.","journal-title":"Cell"},{"key":"ref_159","first-page":"339","article-title":"The relationship of the virus to nasopharyngeal carcinoma","volume-title":"The EpsteinBarr virus","author":"Klein, G.","year":"1979","unstructured":"Klein G. The relationship of the virus to nasopharyngeal carcinoma. In: Epstein MA, Achong BG, eds. The EpsteinBarr virus. Berlin: Springer-Verlag, 1979:339\u201350."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00000478-198908000-00001","article-title":"Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr virus by in situ hybridization","volume":"13","author":"Weiss, L.M.; Movahed, L.A.; Butler, A.E.","year":"1989","unstructured":"Weiss LM, Movahed LA, Butler AE, et al. Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr virus by in situ hybridization. Am J Surg Pathol 1989;13:625\u201331.","journal-title":"Am J Surg Pathol"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/path.1711650105","article-title":"Epstein-Barr virus and carcinomas: undiVerentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus","volume":"165","author":"Niedobitek, G.; Hansmann, M.L.; Herbst, H.","year":"1991","unstructured":"Niedobitek G, Hansmann ML, Herbst H, et al. Epstein-Barr virus and carcinomas: undiVerentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 1991;165:17\u201324.","journal-title":"J Pathol"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1099\/0022-1317-69-5-1051","article-title":"Epstein-Barr virus gene expression in nasopharyngeal carcinoma","volume":"69","author":"Young, L.S.; Dawson, C.W.; Clark, D.","year":"1988","unstructured":"Young LS, Dawson CW, Clark D, et al. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 1988;69:1051\u201365.","journal-title":"J Gen Virol"},{"key":"ref_163","first-page":"879","article-title":"Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undiVerentiated nasopharyngeal carcinomas","volume":"140","author":"Niedobitek, G.; Young, L.S.; Sam, C.K.","year":"1992","unstructured":"Niedobitek G, Young LS, Sam CK, et al. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undiVerentiated nasopharyngeal carcinomas. Am J Pathol 1992;140:879\u201387.","journal-title":"Am J Pathol"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/JVI.66.5.2689-2697.1992","article-title":"Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts","volume":"66","author":"Brooks, L.; Yao, Q.Y.; Rickinson, A.B.","year":"1992","unstructured":"Brooks L, Yao QY, Rickinson AB, et al. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 1992;66:2689\u201397.","journal-title":"J Virol"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1128\/JVI.65.11.6252-6259.1991","article-title":"Expression of the Epstein-Barr virus Bam HI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo","volume":"65","author":"Gilligan, K.; Rajadurai, P.; Lin, J.-C.","year":"1991","unstructured":"Gilligan K, Rajadurai P, Lin J-C, et al. Expression of the Epstein-Barr virus Bam HI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Virol 1991;65:6252\u20139.","journal-title":"J Virol"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1128\/JVI.67.6.3182-3190.1993","article-title":"Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency","volume":"67","author":"Brooks, L.; Lear, A.L.; Young, L.S.","year":"1993","unstructured":"Brooks L, Lear AL, Young LS, et al. Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. J Virol 1993;67:3182\u201390.","journal-title":"J Virol"},{"key":"ref_167","first-page":"358","article-title":"Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells","author":"Cochet, C.; Martel-Renoir, D.; Grunewald, V.","year":"1993","unstructured":"Cochet C, Martel-Renoir D, Grunewald V, et al. Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology 1993;197:358\u201365.","journal-title":"Virology"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3109\/02841869409098448","article-title":"Epstein-Barr virus infection, salted fish and nasopharyngeal carcinoma. A casecontrol study in southern China","volume":"33","author":"Zheng, X.; l, Yan; Nilsson, B.","year":"1994","unstructured":"Zheng X, Yan l, Nilsson B, et al. Epstein-Barr virus infection, salted fish and nasopharyngeal carcinoma. A casecontrol study in southern China. Acta Oncolog 1994;33: 867\u201372.","journal-title":"Acta Oncolog"},{"key":"ref_169","first-page":"3","article-title":"Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undiVerentiated carcinoma of the nasopharynx","volume":"83","author":"Mazeron, M.C.","year":"1996","unstructured":"Mazeron MC. Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undiVerentiated carcinoma of the nasopharynx. Bull Cancer Radiother 1996; 83:3\u20137.","journal-title":"Bull Cancer Radiother"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ijc.2910390106","article-title":"The diVerentiated form of nasopharyngeal carcinoma contains EpsteinBarr virus DNA","volume":"39","author":"Raab-Traub, N.; Flynn, K.; Pearson, G.","year":"1987","unstructured":"Raab-Traub N, Flynn K, Pearson G, et al. The diVerentiated form of nasopharyngeal carcinoma contains EpsteinBarr virus DNA. Int J Cancer 1987;39:25\u20139.","journal-title":"Int J Cancer"},{"key":"ref_171","first-page":"1355","article-title":"and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia","volume":"146","author":"Pathmanathan, R.; Prasad, U.; Chandrika, G.","year":"1995","unstructured":"Pathmanathan R, Prasad U, Chandrika G, et al. UndiVerentiated, non-keratinising, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 1995;146:1355\u201367.","journal-title":"Am J Pathol"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/ijc.2910530507","article-title":"Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ","volume":"53","author":"Yeung, W.M.; Zong, Y.S.; Chiu, C.T.","year":"1993","unstructured":"Yeung WM, Zong YS, Chiu CT, et al. Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ. Int J Cancer 1993;53:746\u201350.","journal-title":"Int J Cancer"},{"key":"ref_173","first-page":"85","article-title":"EBV DNA structure and expression in EBV-induced proliferations","volume-title":"virus and human disease","author":"Raab-Traub, N.; Gilligan, K.; Sato, H.","year":"1988","unstructured":"Raab-Traub N, Gilligan K, Sato H, et al. EBV DNA structure and expression in EBV-induced proliferations. In: Ablashi DV, Faggioni A, Krueger GRF, et al, eds. Epstein-Barr virus and human disease. Clifton, NJ: Humana Press, 1988:85\u201398."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/ijc.2910530616","article-title":"Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a high nasopharyngeal carcinoma risk group","volume":"53","author":"Sam, C.K.; Brooks, L.A.; Niedobitek, G.","year":"1993","unstructured":"Sam CK, Brooks LA, Niedobitek G, et al. Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a high nasopharyngeal carcinoma risk group. Int J Cancer 1993;53:957\u201362.","journal-title":"Int J Cancer"},{"key":"ref_175","first-page":"357","article-title":"Current knowledge of the epidemiology of nasopharyngeal carcinoma","author":"Ho, J.H.C.","year":"1972","unstructured":"Ho JHC. Current knowledge of the epidemiology of nasopharyngeal carcinoma. In: Biggs P, de The G, Payne L, eds. Oncogenesis and herpesviruses. Lyon: IARC, 1972:357\u201366."},{"key":"ref_176","first-page":"107","article-title":"EBER-1 expression in thymic carcinoma","volume":"43","author":"Fujii, T.; Kawai, T.; Saito, K.","year":"1993","unstructured":"Fujii T, Kawai T, Saito K, et al. EBER-1 expression in thymic carcinoma. Acta Pathol Jpn 1993;43:107\u201310.","journal-title":"Acta Pathol Jpn"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1073\/pnas.91.19.9131","article-title":"Gastric carcinoma: monoclonal epithelial malignant cells expressing EpsteinBarr virus latent infection protein","volume":"91","author":"Imai, S.; Koizumi, S.; Sugiura, M.","year":"1994","unstructured":"Imai S, Koizumi S, Sugiura M, et al. Gastric carcinoma: monoclonal epithelial malignant cells expressing EpsteinBarr virus latent infection protein. Proc Natl Acad Sci USA 1994;91:9131\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/ajcp\/99.2.195","article-title":"Uterine cervical lymphoepithelial-like carcinoma. Absence of EpsteinBarr virus","volume":"99","author":"Weinberg, E.; Hoisington, S.; Eastman, A.Y.","year":"1993","unstructured":"Weinberg E, Hoisington S, Eastman AY, et al. Uterine cervical lymphoepithelial-like carcinoma. Absence of EpsteinBarr virus. Am J Clin Pathol 1993;99:195\u20139.","journal-title":"Am J Clin Pathol"},{"key":"ref_179","article-title":"Histological typing of upper respiratory tract tumours","author":"Shanmugaratnam, K.; Sobin, L.H.","year":"1978","unstructured":"Shanmugaratnam K, Sobin LH. Histological typing of upper respiratory tract tumours. Geneva: WHO, 1978."},{"key":"ref_180","first-page":"769","article-title":"Epstein-Barr virus-associated gastric adenocarcinoma","volume":"140","author":"Shibata, D.; Weiss, L.M.","year":"1992","unstructured":"Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 1992;140:769\u201374.","journal-title":"Am J Pathol"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0046-8177(96)90133-1","article-title":"Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation","volume":"27","author":"Gulley, M.L.; Pulitzer, D.R.; Eagan, P.A.","year":"1996","unstructured":"Gulley ML, Pulitzer DR, Eagan PA, et al. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Hum Pathol 1996;27:20\u20137.","journal-title":"Hum Pathol"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1128\/JVI.65.12.7032-7036.1991","article-title":"Epstein-Barr virus infection in carcinoma of the salivary gland","volume":"65","author":"Raab-Traub, N.; Rajadurai, P.; Flynn, K.","year":"1991","unstructured":"Raab-Traub N, Rajadurai P, Flynn K, et al. Epstein-Barr virus infection in carcinoma of the salivary gland. J Virol 1991;65:7032\u20136.","journal-title":"J Virol"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1365-2559.1996.287333.x","article-title":"Epstein-Barr virus latent and replicative gene expression in gastric carcinoma","volume":"28","author":"Selves, J.; Bibeau, F.; Brousset, P.","year":"1996","unstructured":"Selves J, Bibeau F, Brousset P, et al. Epstein-Barr virus latent and replicative gene expression in gastric carcinoma. Histopathology 1996;28:121\u20137.","journal-title":"Histopathology"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00019606-199206000-00003","article-title":"Epstein-Barr virus and carcinomas: expression of the viral genome in an undiVerentiated gastric carcinoma","volume":"1","author":"Niedobitek, G.; Herbst, H.; Young, L.S.","year":"1992","unstructured":"Niedobitek G, Herbst H, Young LS, et al. Epstein-Barr virus and carcinomas: expression of the viral genome in an undiVerentiated gastric carcinoma. Diagn Mol Pathol 1992; 1:103\u20138.","journal-title":"Diagn Mol Pathol"},{"key":"ref_185","first-page":"1376","article-title":"Detection of Epstein-Barr virus in invasive breast cancers","volume":"91","author":"Bonnet, M.; Guinebretiere, J.M.; Kremmer, E.","year":"1990","unstructured":"Bonnet M, Guinebretiere JM, Kremmer E, et al. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 1990;91:1376\u221281.","journal-title":"J Natl Cancer Inst"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/viro.1999.9619","article-title":"Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression","volume":"256","author":"Sugawara, Y.; Mizugaki, Y.; Uchida, T.","year":"1999","unstructured":"Sugawara Y, Mizugaki Y, Uchida T, et al. Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology 1999;256: 196\u2212202.","journal-title":"Virology"}],"container-title":["Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/mp.52.6.307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T17:51:58Z","timestamp":1756057918000},"score":1,"resource":{"primary":{"URL":"https:\/\/mp.bmj.com\/lookup\/doi\/10.1136\/mp.52.6.307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":186,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1999,12,1]]},"published-print":{"date-parts":[[1999,12]]}},"alternative-id":["10.1136\/mp.52.6.307"],"URL":"https:\/\/doi.org\/10.1136\/mp.52.6.307","relation":{},"ISSN":["1366-8714","1472-4154"],"issn-type":[{"value":"1366-8714","type":"print"},{"value":"1472-4154","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}